Amplify YieldShares Oil Hedged MLP Income ETF (AMLX): Price and Financial Metrics ETF
AMLX Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $25.56 | 52-week high | $41.93 |
| Prev. close | $25.27 | 52-week low | $11.83 |
| Day low | $25.02 | Volume | 585,274 |
| Day high | $25.62 | Avg. volume | 944,178 |
| 50-day MA | $28.29 | Dividend yield | N/A |
| 200-day MA | $32.29 |
AMLX Stock Price Chart Interactive Chart >
AMLX Stock Summary
- AMLX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.47 -- higher than merely 5.47% of US-listed equities with positive expected earnings growth.
- AMLX's went public 1.38 years ago, making it older than merely 1.08% of listed US stocks we're tracking.
- As for revenue growth, note that AMLX's revenue has grown 27,047.25% over the past 12 months; that beats the revenue growth of 99.89% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to AMYLYX PHARMACEUTICALS INC, a group of peers worth examining would be NCTY, PRKR, URG, YVR, and OCUP.
- To check out AMYLYX PHARMACEUTICALS INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001658551.
AMLX Valuation Summary
- In comparison to the median Healthcare stock, AMLX's price/earnings ratio is 151.45% lower, now standing at -12.4.
- Over the past 17 months, AMLX's price/sales ratio has gone down 1515.4.
Below are key valuation metrics over time for AMLX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| AMLX | 2023-05-23 | 19.7 | 5.2 | -12.4 | -11.7 |
| AMLX | 2023-05-22 | 19.4 | 5.2 | -12.2 | -11.5 |
| AMLX | 2023-05-19 | 19.2 | 5.1 | -12.0 | -11.3 |
| AMLX | 2023-05-18 | 19.3 | 5.1 | -12.1 | -11.4 |
| AMLX | 2023-05-17 | 19.9 | 5.3 | -12.5 | -11.8 |
| AMLX | 2023-05-16 | 19.5 | 5.2 | -12.3 | -11.6 |
Amplify YieldShares Oil Hedged MLP Income ETF (AMLX) ETF Bio
The investment objective of the Amplify YieldShares Oil Hedged MLP Income ETF is to selects its components from the Oil Hedged MLP Index with the intention of outperforming the index. It also holds short positions in WTI crude oil futures to limit the fund’s correlation with oil prices.
AMLX ETF Info
| Issuer | |
| Expense Ratio | % |
| Asset Class | |
| Sector | MLP ETFs |
| Assets Under Management (AUM) | N/A |
| Net Asset Value (NAV) | $0.00 |
| Options? | No |
| Total Holdings | N/A |
Latest AMLX News From Around the Web
Below are the latest news stories about AMYLYX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMLX as an investment opportunity.
Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European UnionCAMBRIDGE, Mass., May 30, 2023--Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European Union |
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2023 Earnings Call TranscriptAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2023 Earnings Call Transcript May 14, 2023 Lindsey Allen: Good afternoon and thank you for joining today to discuss our First Quarter 2023 Earnings. With me on the call are Josh Cohen and Justin Klee, our Co-CEOs; Margaret Olinger, our Chief Commercial Officer; and Jim Frates, our Chief Financial Officer. […] |
New Forecasts: Here's What Analysts Think The Future Holds For Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) shareholders will have a reason to smile today, with the analysts making... |
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2023 Earnings Call TranscriptAmylyx Pharmaceuticals, Inc. (AMLX) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Lindsey Allen - Head of Investor Relations and Communications Justin Klee - Co-Chief Executive Officer and Co-Founder Margaret Olinger - Global Head of Commercial and CCO James Frates - Chief Financial Officer Josh Cohen - Co-Chief Executive Officer and Co-Founder Conference Call Participants Corinne Jenkins - Goldman Sachs Marc Goodman - SVB Securities Ananda Ghosh - H.C. Wainwright Neena Bitritto-Garg - Citi Presentation Lindsey Allen Good afternoon and thank you for joining today to discuss our First Quarte... |
2 Supercharged Growth Stocks to Buy Right NowDespite a possibe economic recession, the ongoing turmoil among regional banks, rumblings of a potential crisis in commercial real estate, stubbornly high inflation, ever-rising interest rates, and a fair amount of geopolitical tumult, growth stocks have been on the upswing in 2023. The tech-heavy Nasdaq Composite, for example, has clocked a remarkable 17.4% gain so far this year. The core reason is that bargain hunters have been snapping up growth stocks of late after their dramatic decline in value in 2022. |
AMLX Price Returns
| 1-mo | -11.98% |
| 3-mo | -29.20% |
| 6-mo | -30.99% |
| 1-year | 110.02% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -30.83% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |